Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma

Rationale: Platinum-based chemotherapy is one of treatment mainstay for patients with advanced lung squamous cell carcinoma (LUSC) but it is still a “one-size fits all” approach. Here, we aimed to investigate the predictive and monitoring role of circulating cell-free DNA (cfDNA) profiling for the o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Theranostics
Auteurs principaux: Jiang, Tao, Jiang, Liyan, Dong, Xiaorong, Gu, Kangsheng, Pan, Yueyin, Shi, Qin, Zhang, Guojun, Wang, Huijuan, Zhang, Xiaochun, Yang, Nong, Li, Yuping, Xiong, Jianping, Yi, Tienan, Peng, Min, Song, Yong, Fan, Yun, Cui, Jiuwei, Chen, Gongyan, Tan, Wei, Zang, Aimin, Guo, Qisen, Zhao, Guangqiang, Wang, Ziping, He, Jianxing, Yao, Wenxiu, Wu, Xiaohong, Chen, Kai, Hu, Xiaohua, Hu, Chunhong, Yue, Lu, Jiang, Da, Wang, Guangfa, Liu, Junfeng, Yu, Guohua, Li, Junling, Zhang, Henghui, Wu, Lihong, Fang, Lu, Liang, Dandan, Zhao, Yi, Zhao, Weihong, Xie, Wenmin, Ren, Shengxiang, Zhou, Caicun
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2021
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7681090/
https://ncbi.nlm.nih.gov/pubmed/33391473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.51243
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires